Price
$1.94
Decreased by -7.62%
Dollar volume (20D)
8.61 M
ADR%
8.48
Earnings report date
May 23, 2025
Shares float
101.93 M
Shares short
11.60 M [11.38%]
Shares outstanding
143.65 M
Market cap
534.11 M
Beta
0.18
Price/earnings
N/A
20D range
1.88 3.03
50D range
1.88 6.05
200D range
1.88 10.03

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

It operates in two segments, Nucleic Acid Production and Biologics Safety Testing.

The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA).

This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples.

The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services.

This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services.

The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products.

It serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies.

Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Feb 20, 25 -0.06
Decreased by -700.00%
-0.04
Decreased by -49.63%
Nov 7, 24 -0.02
Decreased by -100.00%
-0.01
Decreased by -100.00%
Aug 7, 24 -0.06
Decreased by -11.60%
-0.00
Decreased by -6.88 K%
May 8, 24 -0.02
Decreased by -166.67%
-0.03
Increased by +33.33%
Feb 22, 24 0.01
Decreased by -97.14%
-0.01
Increased by +200.00%
Nov 7, 23 -0.01
Decreased by -102.70%
0.01
Decreased by -200.00%
Aug 7, 23 -0.05
Decreased by -109.26%
0.01
Decreased by -600.00%
May 8, 23 0.03
Decreased by -94.44%
0.04
Decreased by -25.00%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 56.41 M
Decreased by -23.92%
-26.14 M
Increased by +75.33%
Decreased by -46.35%
Increased by +67.57%
Sep 30, 24 65.20 M
Decreased by -2.49%
-99.04 M
Decreased by -1.43 K%
Decreased by -151.90%
Decreased by -1.47 K%
Jun 30, 24 73.40 M
Increased by +6.51%
-7.58 M
Decreased by -15.96%
Decreased by -10.33%
Decreased by -8.87%
Mar 31, 24 64.18 M
Decreased by -18.79%
-12.08 M
Decreased by -795.99%
Decreased by -18.82%
Decreased by -1.00 K%
Dec 31, 23 74.14 M
Decreased by -63.78%
-105.96 M
Decreased by -221.19%
Decreased by -142.92%
Decreased by -434.63%
Sep 30, 23 66.86 M
Decreased by -65.04%
-6.46 M
Decreased by -106.48%
Decreased by -9.66%
Decreased by -118.55%
Jun 30, 23 68.91 M
Decreased by -71.61%
-6.54 M
Decreased by -104.17%
Decreased by -9.49%
Decreased by -114.70%
Mar 31, 23 79.03 M
Decreased by -67.65%
-1.35 M
Decreased by -100.92%
Decreased by -1.71%
Decreased by -102.84%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY